Trinity Biotech | TRIB - Current Assets


Trinity Biotech reported $35.52M in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Abbott USD 26B 1.16B Dec/2025
Bayer EUR 32.88B 873M Sep/2025
Bio-Rad Laboratories USD 2.91B 64.2M Dec/2025
EDAP TMS EUR 51.48M 6.99M Jun/2025
J&J USD 55.62B 1.01B Dec/2025
Mesa Laboratories USD 105.63M 8.2M Dec/2025
OraSure Technologies USD 283.01M 18.43M Sep/2025
Plus Therapeutics USD 9.83M 1.75M Dec/2023
Roche Holding CHF 38.73B 3.03B Dec/2025
Siemens EUR 67.91B 3.2B Dec/2025
Surmodics USD 81.3M 948K Sep/2024
Thermo Fisher Scientific USD 28.71B 6.41B Dec/2025
Tosoh JPY 759.27B 28.26B Dec/2025
Trinity Biotech USD 35.52M 2.52M Sep/2025
Veracyte USD 449.22M 34.54M Sep/2025